Insight Pharmaceuticals is recalling 34,704 cans of Americaine (benzocaine 20%) Benzocaine Topical Anesthetic Spray due to the presence of benzene, a chemical contaminant. Benzene was detected in the aerosol spray during testing, although it is not an intended ingredient in the product. The recall affects 2 oz aerosol cans sold at retailers across the United States. No injuries or adverse events have been reported to date.
Benzene is classified as a human carcinogen. Long-term exposure through inhalation, skin contact, or ingestion can result in life-threatening blood cancers such as leukemia and other serious blood disorders.
You have 2 options:
Distributed by Insight Pharmaceuticals Corp. Tarrytown, NY.

Image 1 โ Labeling โ Americaine Benzocaine Tropical Anesthetic Spray 2 oz
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท FDA Press Release ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.